breast cancer and glp 1 drugs GLP-1 cut risk by 30%? Not so fast GLP-1 drugs linked to improved
Description
The administration of the triple agonist resulted in the improvement of steatohepatitis in a dose-dependent fashion, with some female mice showing a complete resolution
EBioMedicine 93 , 104642 (2023)
Additionally, they activate the AMPK pathway in liver cells, which promotes fatty acid oxidation and reduces lipid accumulation (lipogenesis), offering potential benefits for non-alcoholic fatty liver disease (NAFLD) (Zheng et al., 2024)
J Clin Neurosci 95:172179
